By Nicholas Freudenberg for the Symposium of the Geneesmiddelenbulletin on June 30th 2016 in Leiden ’Science and Economy’. It was also translated and published in the Bulletin.
In the last two decades, the public health community has generally agreed that the tobacco industry has no role in setting health policy or sponsoring research on tobacco. The Framework Convention on Tobacco Control bans industry participation in policy deliberations on Tobacco, most major global public health organizations and national health departments have sharply limited their interactions with representatives of the tobacco industry, and many universities and some journals no longer accept or publish research supported by the tobacco industry.
However, no such agreement has been reached on the appropriate role for corporations and trade associations in other sectors such as pharmaceuticals, food and beverages, and alcohol. Some health and business analysts emphasize that the different roles that the products of the tobacco, medicines, food and alcohol industries play in patterns of health and disease make any judgments inappropriate and misguided, especially in the case of the drug industry. “Such comparisons (between the tobacco and pharmaceutical industries) are not just absurd, they are irresponsible as they contribute to patients not taking prescribed medicines that can clearly benefit them”, wrote one former drug industry executive. Read more
For many Missouri health advocates, an increase in the state’s tobacco tax is long overdue. But, according to the California public radio station KCLU, onlookers might be surprised to hear that tobacco companies are spending a fortune this election year to get one or another increase in that tax passed, while health groups are urging a no vote. Groups like Tobacco Free Missouri, the Health Care Foundation of Greater Kansas City and Campaign for Tobacco-Free Kids have joined fiscal conservatives in opposing Amendment 3. These anti-smoking groups worry that creating such a small tax now might eliminate the chance of future tax that would be big enough to significantly change smokers’ behavior.
Thirty years of research in tobacco control has shown that countermarketing has been effective in reducing tobacco use, especially among teenagers and young adults. This policy brief by investigators at the City University of New York Urban Food Policy Institute describes some of the key elements of effective tobacco countermarketing campaigns, and examines the relevance of these evidence-based countermarketing practices to unhealthy food and beverages, defined as processed products high in unhealthy fats, sugar, salt and empty calories
A new report in The Milbank Quarterly concludes that passing e-cigarette regulations at the state level has become more difficult since cigarette companies have entered the market. While state legislation is possible, as with earlier tobacco control policymaking, local governments remain a viable option for overcoming cigarette company interference in the policymaking process. Citation: Cox E, Barry RA, Glantz S. E-cigarette Policymaking by Local and State Governments: 2009-2014. The Milbank Quarterly 2016; 94(3): 520–596.
Case Studies on Corporations & Global Health Governance, edited by Nora Kenworthy, Ross MacKenzie and Kelley Lee, presents interdisciplinary case studies on how corporations influence global health governance and how they could be held more accountable. The empirical studies examine several industries across high, low and middle income countries and explore the impact of corporations and their allies on the governance processes that shape population health.
“Exxon and its allies have dismissed comparisons to Big Tobacco as baseless”, writes Smoke and Fumes, a project of the Center for International Environmental Law. “Our research in more than 14 million documents of the Tobacco Industry Archives reveals compelling evidence that the relationship between these two industries is neither coincidental nor casual. Beyond a doubt, the oil companies have benefitted from the tobacco playbook in their fight against climate science. But the question arises, where did the tobacco companies get their playbook in the first place?” Read more.
In his new book, Moral Jeopardy: Risks of Accepting Money from the Alcohol, Tobacco and Gambling Industries (Cambridge University Press, 2016), Peter Adams examines the ethical issues that arise when people and organizations accept money from tobacco, alcohol and gambling corporations. Adams is professor and deputy head of the School of Population Health at the University of Auckland in New Zealand and an associate director of its Centre for Addiction Research. Corporations and Health Watch’s Nick Freudenberg conducted this e-mail interview of Adams. Continue reading Moral Jeopardy: What are the risks of accepting money from the alcohol, tobacco and gambling industries?